Kurs
-0,37%
Likviditet
277 MSEK
Kalender
Tid* | ||
2025-10-23 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-07-17 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-04-24 | 07:00 | Kvartalsrapport 2025-Q1 |
2025-03-27 | N/A | Årsstämma |
2025-01-23 | 07:00 | Bokslutskommuniké 2024 |
2024-10-24 | - | Kvartalsrapport 2024-Q3 |
2024-07-18 | - | Kvartalsrapport 2024-Q2 |
2024-04-25 | - | Kvartalsrapport 2024-Q1 |
2024-03-22 | - | X-dag ordinarie utdelning ESSITY A 7.75 SEK |
2024-03-22 | - | X-dag ordinarie utdelning ESSITY B 7.75 SEK |
2024-03-21 | - | Årsstämma |
2024-01-25 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-20 | - | Kvartalsrapport 2023-Q2 |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-03-30 | - | X-dag ordinarie utdelning ESSITY A 7.25 SEK |
2023-03-30 | - | X-dag ordinarie utdelning ESSITY B 7.25 SEK |
2023-03-29 | - | Årsstämma |
2023-01-26 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-07-21 | - | Kvartalsrapport 2022-Q2 |
2022-04-22 | - | Kvartalsrapport 2022-Q1 |
2022-03-25 | - | X-dag ordinarie utdelning ESSITY A 7.00 SEK |
2022-03-25 | - | X-dag ordinarie utdelning ESSITY B 7.00 SEK |
2022-03-24 | - | Årsstämma |
2022-01-26 | - | Bokslutskommuniké 2021 |
2021-10-22 | - | Kvartalsrapport 2021-Q3 |
2021-07-16 | - | Kvartalsrapport 2021-Q2 |
2021-04-23 | - | Kvartalsrapport 2021-Q1 |
2021-03-26 | - | X-dag ordinarie utdelning ESSITY A 6.75 SEK |
2021-03-26 | - | X-dag ordinarie utdelning ESSITY B 6.75 SEK |
2021-03-25 | - | Årsstämma |
2021-01-27 | - | Bokslutskommuniké 2020 |
2020-10-29 | - | X-dag ordinarie utdelning ESSITY A 6.25 SEK |
2020-10-29 | - | X-dag ordinarie utdelning ESSITY B 6.25 SEK |
2020-10-28 | - | Extra Bolagsstämma 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-07-13 | - | Kvartalsrapport 2020-Q2 |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-04-02 | - | Årsstämma |
2020-01-22 | - | Bokslutskommuniké 2019 |
2019-10-25 | - | Kvartalsrapport 2019-Q3 |
2019-07-18 | - | Kvartalsrapport 2019-Q2 |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-04-05 | - | X-dag ordinarie utdelning ESSITY A 5.75 SEK |
2019-04-05 | - | X-dag ordinarie utdelning ESSITY B 5.75 SEK |
2019-04-04 | - | Årsstämma |
2019-01-31 | - | Bokslutskommuniké 2018 |
2018-10-29 | - | Kvartalsrapport 2018-Q3 |
2018-07-19 | - | Kvartalsrapport 2018-Q2 |
2018-04-27 | - | Kvartalsrapport 2018-Q1 |
2018-04-13 | - | X-dag ordinarie utdelning ESSITY A 5.75 SEK |
2018-04-13 | - | X-dag bonusutdelning ESSITY A 5.75 |
2018-04-13 | - | X-dag ordinarie utdelning ESSITY B 5.75 SEK |
2018-04-12 | - | Årsstämma |
2018-01-25 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-07-18 | - | Kvartalsrapport 2017-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Handel & varor |
Industri | Dagligvaror |
Hygiene and health company Essity is expanding its production of athletics tape by investing in a new production line for Leukotape K. The investment enables a significant increase in production capacity to meet the growing global demand.
Leukotape K is an elastic kinesiology tape which has been successfully used for many years to relieve pain, treat swelling and discomfort and improve function for athletes and patients in both daily practice and in hospitals. Leukotape K is sold in more than 90 countries around the world.
The new fully automated production line is located at Essity's site in Vibraye, France and will fivefold the production capacity of Leukotape K. The investment amounted to EUR 1m.
"We are proud to announce that we are expanding the production at our Vibraye site, dedicated to producing high-quality medical solutions. Leukotape K enables recovery from injury and is managing pain during demanding sports for amateur and professional athletes around the world", says Ulrika Kolsrud, President Health & Medical, Essity.
The production facility in France can annually produce more than 10 million m2 (or about 1 400 football fields) of elastic adhesive tape under Essity's brands Actimove, Leukoplast and Tensoplast.
Essity is the world's third largest player within non-invasive orthopedic products. Solutions are offered for skeletal, muscular and joint injuries as well as for chronic conditions such as arthritis. The product assortment includes products such as casts, splints, braces support products and athletic tapes.
For further information, please contact:
Karl Stoltz, Media Relations Director, +46 709 42 63 88, karl.stoltz@essity.com